Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: HCQ in Resectable Localized Prostate Cancer [EARLY_Phase 1]
Hydroxychloroquine is being studied in an early-phase (Phase 1) trial for resectable localized prostate cancer. The study is currently recru…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies
This document provides an update on a UK genetic study of prostate cancer, focusing on epidemiology and molecular genetics, with the trial c…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial [Phase 3]
Phase 3 trial evaluating stereotactic ablative radiotherapy (SABR) for oligometastatic metastatic cancer; currently recruiting. The study in…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: The Active Surveillance Study
The active surveillance study for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: PSMA PET Registry (18F-DCFPyL) [NA]
This document reports the completion status of a PSMA PET imaging registry using the radiopharmaceutical 18F-DCFPyL for prostate cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy
Clinical trial update describing gene expression analyses in patients with metastatic prostate cancer treated with a CYP-17 inhibitor.
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Physician- and Patient-based Barriers to NGS Testing [NA]
A clinical trial studying why physicians and patients face barriers to using next-generation sequencing testing in metastatic prostate cance…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe) [Phase 2]
Phase 2 clinical trial evaluating a cardio-oncology consultation intervention to reduce cardiovascular risk in prostate cancer patients afte…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer [EARLY_Phase 1]
This is an early-phase 1 platform clinical trial evaluating an epigenetic therapy before prostatectomy in men with high-risk prostate cancer…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Partial Prostate Salvage High Dose Rate Brachytherapy [NA]
A recruiting clinical trial is evaluating partial salvage high-dose-rate brachytherapy for recurrent prostate cancer, sponsored by the Briti…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Prostate Cancer REsearch Using Cross-validation of Innovative Sampling, Integrating LC-MS/MS for Optimized Therapeutic Drug moNitoring
An ongoing prostate cancer study at Centro di Riferimento Oncologico - Aviano investigates innovative sampling methods with LC-MS/MS–based t…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) [NA]
The PROMPT clinical trial is currently recruiting to compare 5500/20 therapy against SABR or brachytherapy for primary treatment of oligomet…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors [Phase 1]
Phase 1 clinical trial update indicates a study of Olaparib in combination with ASTX727 for BRCA1/2- and homologous recombination deficiency…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Prostate Ablation Registry and Database for Information, Surveillance, and Evaluation (PARADISE)
The PARADISE study is a University of Chicago–sponsored registry and database for information, surveillance, and evaluation of prostate abla…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Salvage Ultrahypofractionated Postoperative External Radiotherapy For Biochemical Recurrence
This clinical trial update describes salvage ultrahypofractionated postoperative external radiotherapy for biochemical recurrence after pros…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy Participants
The update describes a clinical investigation into identifying prostate cancer–specific markers by comparing patients with healthy participa…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) [NA]
Completed clinical trial PREPARE evaluated a geriatric intervention in the treatment of older cancer patients. The update does not include t…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.
An ongoing study evaluating clinical outcomes and dosimetry in patients with prostate cancer treated with 177Lu-PSMA-617, including metastat…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study
Update on the GIFTS study investigating how genetic information can guide treatment and screening for prostate cancer, currently enrolling b…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study [NA]
Clinical trial update for the RedSedCan study evaluating whether reducing sedentary behavior during cancer treatment affects outcomes. The s…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Plant-based Diets and Risk of Cancer in the Adventist Health Study-2
Clinical trial update examining whether plant-based diets influence cancer risk in the Adventist Health Study-2; the study is currently acti…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Pembro With Radiation With or Without Olaparib [Phase 2]
A Phase 2 clinical trial evaluates pembrolizumab with radiation, with or without olaparib, for prostate cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer [Phase 2]
This update describes a Phase 2 study evaluating MRI-guided high-dose radiation therapy for prostate cancer. The trial is currently active b…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer [NA]
This ClinicalTrials.gov update reports a University of Alberta-sponsored study examining continence, sexual function, fitness, and health ou…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise [NA]
A clinical trial update on a digital exercise intervention aimed at improving health outcomes and promoting engagement in regular exercise f…